Activity of butenafine against ocular pathogenic filamentous fungi in vitro

Chinese Journal of Ophthalmology

Volumn 46, Issue 1, 2010, Pages 38-42

  Xu, Yan ^a   Pang, Guang Ren ^a   Zhao, Dong Qing ^a   Gao, Chuan Wen ^a   Zhou, Lu Tan ^a   Sun, Sheng Tao ^a   Wang, Bing Liang ^a   Chen, Zu Ji ^a  

^a Henan Eye Institute   (China)

Author keywords

Antifungal agents; Benzylamines; Fungi; Microbial sensitivity tests; Naphthalenes

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; BENZYLAMINE DERIVATIVE; BUTENAFINE; FLUCONAZOLE; NAPHTHALENE DERIVATIVE; NATAMYCIN;

ARTICLE; COMPARATIVE STUDY; DRUG EFFECT; FUNGAL EYE INFECTION; FUNGUS; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; BENZYLAMINES; EYE INFECTIONS, FUNGAL; FLUCONAZOLE; FUNGI; HUMANS; MICROBIAL SENSITIVITY TESTS; NAPHTHALENES; NATAMYCIN;

EID: 77956531094     PISSN: 04124081     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0412-4081.2010.01.010     Document Type: Article

References (30)

1. Sun XG, Wang ZX, Wang ZQ, et al. Ocular fungal isolates and antifungal susceptibility in northern China. Am J Ophthalmol, 2007,143:131-133.
2. Singal A, Pandhi D, Agrawal S, et al. Comparative efficacy of topical 1% butenafine and 1% clotrimazole in tinea cruris and tinea corporis; a randomized, double-blind trial. J Dermatolog Treat, 2005,16:331-335.
3. McNeely W, Spencer CM. Butenafine. Drugs,1998,55:405-412.
4. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard M38-A. Wayne: National Committee for Clinical Laboratory Standards, 2003.
5. Qiu WY, Yao YF, Zhu YF, et al. Fungal spectrum identified by a new slide culture and in vitro drug susceptibility using Etest in fungal keratitis. Curr Eye Res, 2005,30:1113-1120.
6. Hofling-Lima AL, Forseto A, Duprat JP, et al. Laboratory study of the mycotic infectious eye diseases and factors associated with keratitis. Arq Bras Oftalmol, 2005,68:21-27.
7. Wong TY, Fong KS, Tan DT. Clinical and microbial spectrum of fungal keratitis in Singapore; a 5-year retrospective study. Int Ophthalmol, 1997,21:127-130.
8. Bhartiya P, Danieli M, Constantinou M. Fungal keratitis in Melbourne. Clin Exp Ophthalmol, 2007,35:124-130.
9. Tanure MA, Cohen EJ, Sudesh S, et al. Spectrum of fungal keratitis at Wills Eye Hospital, Philadelphia, Pennsylvania. Cornea, 2000,19:307-312.
10. Saha R, Das S. Mycological profile of infectious keratitis from Delhi. Indian J Med Res, 2006,123:159-164.
11. Chowdhary A, Singh K. Spectrum of fungal keratitis in North India. Cornea, 2005,24:8-15.
12. Khaieallah SH, Byrne KA, Tabbara, KF. Fungal keratitis in Saudi Arabia. Doc Ophthalmol, 1992,79: 269-276.
13. Khanal B, Deb M, Panda A, et al. Laboratory diagnosis in ulcerative keratitis. Ophthalmic Res, 2005,37: 123-127.
14. Lalitha P, Shapiro BL, Srinivasan M, et al. Antimicrobial susceptibility of fusarium, aspergillus, and other filamentous fungi isolated from keratitis. Arch Ophthalmol, 2007,125:789-793.
15. Iwatani W, Arika T, Yamaguchi H. Two mechanisms of butenafine action in Candida albicans. Antimicrob Agent Chemother, 1993, 37:785-788.
16. Nahm WK, Orengo I, Rosen T. Trie antifungal agent butenafine manifests anti-inflammatory activity in vivo. J Am Acad Dermatol, 1999,41:203-206.
17. Schreiber W, Olbrisch A, Vorwerk CK, et al. Combined topical fluconazole and corticosteroid treatment for experimental Candida albicans keratomycosis. Invest Ophthalmol Vis Sci, 2003, 44 : 2634-2643.
18. Peponis V, Herz JB, Kaufman HE. The role of corticosteroids in fungal keratitis : a different view. Br J Ophthalmol, 2004, 88 : 1227.
19. Pineda R, Dolhman CH. The role of steroids in the management of acanthamoeba keratitis, fungal keratitis and epidemic keratoconjunctivitis. Int Ophthal Clin,1994,34:19-31.
20. Stem GA, Buttross M. Use of corticosteroids in combination with antimicrobial drugs in the treatment of infectious corneal disease. Ophthalmology, 1991,98:847-853.
21. Thomas PA. Current perspectives on ophthalmic mycoses. Clin Microb Rev, 2003,16:730-797.